Health Service Medical Supplies (Costs) Act 2017

Type Public General Act
Publication 2017-04-27
State In force
Department Statute Law Database
Reform history JSON API

Controlling cost of health service medicines

Remuneration for persons providing special medicinal products: England

1

In section 164 of the National Health Service Act 2006 (remuneration for persons providing pharmaceutical services), after subsection (8) insert—

(8A) Regulations may impose requirements in relation to remuneration in respect of special medicinal products. (8B) Such regulations may, for example, require determining authorities to ensure— (a) that remuneration is to be calculated by reference to the outcome of prescribed procedures, or (b) that determinations do not provide for or permit remuneration to be paid in prescribed circumstances. (8C) Procedures prescribed by virtue of subsection (8B)(a) may include the person to whom remuneration is payable, a health service body or a determining authority— (a) carrying out inquiries to ensure that remuneration is reasonable, or (b) estimating an amount of remuneration that is reasonable (whether or not the estimated amount corresponds exactly to expenses in respect of which remuneration is to be paid). (8D) Circumstances prescribed by virtue of subsection (8B)(b) may include circumstances in which special medicinal products are made available to persons who provide pharmaceutical services under this Part— (a) by a health service body, or (b) under an arrangement for the supply of special medicinal products to which a health service body is a party. (8E) In subsections (8A) to (8D)— - “health service body” has the meaning given by section 9(4); - “special medicinal product” means a product which is a special medicinal product for the purposes of regulation 167 of the Human Medicines Regulations 2012 (S.I. 2012/1916).

Remuneration for persons providing special medicinal products: Wales

2

In section 88 of the National Health Service (Wales) Act 2006 (remuneration for persons providing pharmaceutical services), after subsection (8) insert—

(8A) Regulations may impose requirements in relation to remuneration in respect of special medicinal products. (8B) Such regulations may, for example, require determining authorities to ensure— (a) that remuneration is to be calculated by reference to the outcome of prescribed procedures, or (b) that determinations do not provide for or permit remuneration to be paid in prescribed circumstances. (8C) Procedures prescribed by virtue of subsection (8B)(a) may include the person to whom remuneration is payable, a health service body or a determining authority— (a) carrying out inquiries to ensure that remuneration is reasonable, or (b) estimating an amount of remuneration that is reasonable (whether or not the estimated amount corresponds exactly to expenses in respect of which remuneration is to be paid). (8D) Circumstances prescribed by virtue of subsection (8B)(b) may include circumstances in which special medicinal products are made available to persons who provide pharmaceutical services under this Part— (a) by a health service body, or (b) under an arrangement for the supply of special medicinal products to which a health service body is a party. (8E) In subsections (8A) to (8D)— - “health service body” has the meaning given by section 7(4); - “special medicinal product” means a product which is a special medicinal product for the purposes of regulation 167 of the Human Medicines Regulations 2012 (S.I. 2012/1916).

Voluntary schemes

3

(c) providing for any manufacturer or supplier to whom the scheme relates to pay to the Secretary of State an amount calculated by reference to sales or estimated sales of any health service medicines (whether on the basis of net prices, average selling prices or otherwise).

(9) The Secretary of State may provide for any amount payable in accordance with a voluntary scheme by any manufacturer or supplier to whom the scheme applies to be paid to the Secretary of State within a specified period. (10) Neither of the following affects any liability of a manufacturer or supplier to pay amounts to the Secretary of State arising during a period when a health service medicine was covered by a voluntary scheme treated as applying to the person or the taking of any action in relation to any such liability— (a) the withdrawal of consent by the person to the scheme being treated as applying to the person; (b) the giving of notice to the person under subsection (4).

Power to control prices

4

For section 262(2) of the National Health Service Act 2006 (circumstances in which powers not exercisable) substitute—

(2) If at any time a health service medicine is covered by a voluntary scheme applying to its manufacturer or supplier, the powers conferred by this section may not be exercised at that time in relation to that manufacturer or supplier as regards that medicine.

Statutory schemes

5

(c) providing for any manufacturer or supplier of any health service medicines to pay to the Secretary of State an amount calculated by reference to sales or estimated sales of those medicines (whether on the basis of net prices, average selling prices or otherwise).

(1A) Consultation about the proposed exercise of a power under subsection (1) must include consultation about the following— (a) the economic consequences for the life sciences industry in the United Kingdom; (b) the consequences for the economy of the United Kingdom; (c) the consequences for patients to whom any health service medicines are to be supplied and for other health service patients.

(5A) The scheme may provide for any amount payable in accordance with the scheme by any manufacturer or supplier to whom the scheme applies to be paid to the Secretary of State within a specified period.

(7) If at any time a health service medicine is covered by a voluntary scheme applying to its manufacturer or supplier, the powers conferred by this section may not be exercised at that time in relation to that manufacturer or supplier as regards that medicine.

(8) Subsection (7) does not affect any liability of a person to pay amounts to the Secretary of State arising during a period when a health service medicine was covered by a statutory scheme applying to the person or the taking of any action in relation to any such liability.

Enforcement

6

(8A) Subsection (8) does not apply to any action by the Secretary of State to recover as a debt any amount required to be paid to the Secretary of State by virtue of any of sections 261 to 263 or this section.

(4A) The power under section 263(1)(c) is exercisable only with a view to requiring payments to be made which would be reasonable in all the circumstances, bearing in mind in particular— (a) the need for medicinal products to be available for the health service on reasonable terms, and (b) the costs of research and development.

Controlling cost of other medical supplies

Control of maximum price of other medical supplies

7

(1A) Before making an order under subsection (1) the Secretary of State must consult any body which appears to the Secretary of State appropriate to represent persons who manufacture, distribute or supply medical supplies falling within subsection (1).

(aa) the first order under section 260,

.

Information about medical supplies etc

Provision of information to Secretary of State and disclosure

8

After section 264 of the National Health Service Act 2006 insert—

Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.